Non-profit · founded 1947
Lovelace Respiratory Research Institute
Albuquerque, United States · lrri.org
- Citations, last 5 years
- 452
- Works, last 5 years
- 46
- h-index
- 208
- Scientists listed
- 4
- Grants since 2016
- 130
Grants received
2018–2022 · contract · N01
GENE THERAPY RESOURCE PROGRAM (GTRP): PHARMACOLOGY AND TOXICOLOGY CORE LABORATORY SCIENTIFIC ACTIVITIES
Christopher Denman · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2018–2020 · research · R03
The hexosamine biosynthesis pathway in human bronchial epithelial cell transformation.
Wenshu Chen · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2018–2020 · cooperative agreement · U01
DNA Repair Capacity Assays for Lung Disease Risk Assessment
Steven A Belinsky · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2018–2024 · cooperative agreement · U01
DNA Repair Capacity Assays for Lung Disease Risk Assessment
Steven A Belinsky · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2018–2023 · contract · N01
GENE THERAPY RESOURCE PROGRAM (GTRP): PHARMACOLOGY AND TOXICOLOGY CORE LABORATORY SCIENTIFIC ACTIVITIES
Christopher Denman · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2018–2023 · program · P30
Phase III COBRE: Multimodal Imaging of Neuropsychiatric Disorders (MIND)
Andrew Robert Mayer · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2018–2023 · program · P30
Phase III COBRE: Multimodal Imaging of Neuropsychiatric Disorders (MIND)
Andrew Robert Mayer · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2018–2020 · research · R03
The hexosamine biosynthesis pathway in human bronchial epithelial cell transformation.
Wenshu Chen · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2018–2023 · cooperative agreement · U01
DNA Repair Capacity Assays for Lung Disease Risk Assessment
Steven A Belinsky · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2018–2023 · cooperative agreement · U01
DNA Repair Capacity Assays for Lung Disease Risk Assessment
Steven A Belinsky · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2018–2023 · cooperative agreement · U01
DNA Repair Capacity Assays for Lung Disease Risk Assessment
Steven A Belinsky · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2018–2021 · research · R01
Assessing Toxicant Properties of Cigarillo and Hookah Aerosols in Lung Epithelial and Cardiac Cells Through Aerosol Exposure
Steven A Belinsky · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2018–2025 · program · P30
Phase III COBRE: Multimodal Imaging of Neuropsychiatric Disorders (MIND)
Andrew Robert Mayer · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2018–2025 · program · P30
Pilot Project Program (PPP)
Andrew Robert Mayer · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2018–2025 · program · P30
Multimodal Data Acquisition (MDA) Core
Julia Marie Stephen · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2018–2025 · program · P30
Biostatistics and Neuroinformatics (BNI) Core
Erik Barry Erhardt · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2018–2025 · program · P30
Administrative Core
Andrew Robert Mayer · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2018–2025 · program · P30
Algorithm and Data Analysis (ADA) Core
Andrew Robert Mayer · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2017–2024 · contract · N01
ANIMAL MODELS OF INFECTIOUS DISEASES SUPPORT
(Contact) · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2017–2024 · research · R01
Externalizing outcomes in high risk youth
Kent A Kiehl · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2017 · contract · N01
Task B1: ANIMAL MODELS OF INFECTIOUS DISEASES SUPPORT
Katie Ann Overheim · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2017–2018 · contract · N01
DEVELOP A QUALITY ASSURANCE/QUALITY CONTROL (QA/QC) PLAN FOR ACTIVITIES CONDUCTED UNDER TASK AREA C.
Mathew Reed · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2017–2024 · contract · N01
ANIMAL MODELS OF INFECTIOUS DISEASES SUPPORT
(Contact) · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2017 · contract · N01
Task C01: ANIMAL MODELS OF INFECTIOUS DISEASES SUPPORT
Katie Ann Overheim · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2017–2024 · contract · N01
Task B07: Nonhuman Primate Model Development for Enterovirus D68 (EV-D68)
Megan Vermillion · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2016–2021 · research · R01
Inhaled Delivery of Vidaza for Targeted Epigenetic Lung Cancer Therapy
Steven A Belinsky · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2016–2020 · research · R01
Deposition Profile and Toxicology of E-Cigarettes in the Oral Epithelium
Steven A Belinsky · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2016–2023 · research · R01
Inhaled Delivery of Vidaza for Targeted Epigenetic Lung Cancer Therapy
Steven A Belinsky · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2016–2018 · research · R21
Targeting RIP3-mediated Necroptosis for Chemosensitization
Yong Lin · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2016–2022 · research · R01
Aerosol Delivery of Topotecan for Personalized Lung Cancer Therapy
Philip Kuehl · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2016–2020 · research · R01
Deposition Profile and Toxicology of E-Cigarettes in the Oral Epithelium
Steven A Belinsky · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2016–2021 · research · R01
Aerosol Delivery of Topotecan for Personalized Lung Cancer Therapy
Philip Kuehl · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2016–2021 · research · R01
Aerosol Delivery of Topotecan for Personalized Lung Cancer Therapy
Philip Kuehl · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2016–2021 · research · R01
Inhaled Delivery of Vidaza for Targeted Epigenetic Lung Cancer Therapy
Steven A Belinsky · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2016–2021 · research · R01
Aerosol Delivery of Topotecan for Personalized Lung Cancer Therapy
Philip Kuehl · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2016–2022 · research · R01
Inhaled Delivery of Vidaza for Targeted Epigenetic Lung Cancer Therapy
Steven A Belinsky · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2016–2018 · fellowship · F32
Bik and Bcl-2 regulate Nuclear Factor-kappaB-mediated inflammation
Jane Tully Jones · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2016–2021 · research · R01
Inhaled Delivery of Vidaza for Targeted Epigenetic Lung Cancer Therapy
Steven A Belinsky · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2016–2018 · fellowship · F32
Bik and Bcl-2 regulate Nuclear Factor-kappaB-mediated inflammation
Jane Tully Jones · Lovelace Respiratory Research Institute · funded by National Institutes of Health
2016 · research · R21
Targeting Hyperplastic Airway Cells Using a Small Molecule Inhibitor
Hitendra Singh Chand · Lovelace Respiratory Research Institute · funded by National Institutes of Health
